J. Michael Pearson
2012 - Valeant Pharmaceuticals International
In 2012, J. Michael Pearson earned a total compensation of $6.1M as Chief Executive Officer at Valeant Pharmaceuticals International, a 83% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,827,056 |
|---|---|
| Salary | $1,712,500 |
| Other | $573,419 |
| Total | $6,112,975 |
Pearson received $3.8M in non-equity incentive plan, accounting for 63% of the total pay in 2012.
Pearson also received $1.7M in salary and $573.4K in other compensation.
Rankings
In 2012, J. Michael Pearson's compensation ranked 931st out of 11,487 executives tracked by ExecPay. In other words, Pearson earned more than 91.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 931 out of 11,487 | 92nd |
Division Manufacturing | 339 out of 4,253 | 92nd |
Major group Chemicals And Allied Products | 77 out of 1,198 | 94th |
Industry group Drugs | 42 out of 920 | 95th |
Industry Pharmaceutical Preparations | 38 out of 700 | 95th |
Source: SEC filing on April 9, 2015.
Pearson's colleagues
We found three more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2012.